NSE · BALPHARMA
Bal Pharma Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,565
of 5,072 stocks
▲ 371W
Peak #2,565 · 27 Sep 2026
Bal Pharma Limited, a microcap Healthcare business, is growing revenue modestly, commands a premium earnings multiple, and posts a modest return on equity.
Market Cap
171.48 Cr
P/E Ratio
27.27
P/B Ratio
2.08
ROE
7.68%
ROCE
18.01%
Dividend Yield
1.11%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 88.62 Cr | 84.08 Cr | 87.69 Cr | 74.02 Cr |
| Net Profit | 1.14 Cr | 3.60 Cr | 1.79 Cr | 71.73 L |
| EPS | 0.71 | 2.26 | 1.12 | 0.45 |
| Operating Profit | 5.60 Cr | 7.27 Cr | 6.64 Cr | 4.58 Cr |
Shareholding pattern
Promoter
50.86%
Public
49.14%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 17 Sep 2026 | Dividend | Dividend - Rs 1.20 Per Share |
| 18 Sep 2025 | Dividend | Dividend - Rs 1.20 Per Share |
| 17 Sep 2024 | Dividend | Annual General Me0etingdividend - Rs 1.2 Per Share |
| 18 Sep 2023 | Dividend | Annual General Meeting/Dividend - Re 1 Per Share |
| 13 Sep 2022 | Dividend | Annual General Meetingdividend - Re 1 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.